BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30730576)

  • 21. Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis.
    Yao M; Zhu M; Sinz MW; Zhang H; Humphreys WG; Rodrigues AD; Dai R
    J Pharm Biomed Anal; 2007 May; 44(1):211-23. PubMed ID: 17418993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry.
    Qin CZ; Ren X; Tan ZR; Chen Y; Yin JY; Yu J; Qu J; Zhou HH; Liu ZQ
    Biomed Chromatogr; 2014 Feb; 28(2):197-203. PubMed ID: 23946123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory Mechanisms of Lekethromycin in Dog Liver Cytochrome P450 Enzymes Based on UPLC-MS/MS Cocktail Method.
    Sun P; Cao Y; Qiu J; Kong J; Zhang S; Cao X
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
    Bu HZ; Magis L; Knuth K; Teitelbaum P
    Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds.
    Zientek M; Miller H; Smith D; Dunklee MB; Heinle L; Thurston A; Lee C; Hyland R; Fahmi O; Burdette D
    J Pharmacol Toxicol Methods; 2008; 58(3):206-14. PubMed ID: 18634893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS/MS.
    Pillai VC; Strom SC; Caritis SN; Venkataramanan R
    J Pharm Biomed Anal; 2013 Feb; 74():126-32. PubMed ID: 23245243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay.
    Turpeinen M; Uusitalo J; Jalonen J; Pelkonen O
    Eur J Pharm Sci; 2005 Jan; 24(1):123-32. PubMed ID: 15626586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry.
    Testino SA; Patonay G
    J Pharm Biomed Anal; 2003 Jan; 30(5):1459-67. PubMed ID: 12467917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Jeong HU; Lee HS
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of GC-MS based cytochrome P450 assay for the investigation of multi-herb interaction.
    Oh HA; Lee H; Kim D; Jung BH
    Anal Biochem; 2017 Feb; 519():71-83. PubMed ID: 28007398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail.
    Dinger J; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2014 Jul; 406(18):4453-64. PubMed ID: 24830396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
    Zhang S; Song N; Li Q; Fan H; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):78-89. PubMed ID: 18614408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
    Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
    Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
    Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
    Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry.
    Dierks EA; Stams KR; Lim HK; Cornelius G; Zhang H; Ball SE
    Drug Metab Dispos; 2001 Jan; 29(1):23-9. PubMed ID: 11124225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct inhibition of Re Du Ning Injection and its active compounds on human liver cytochrome P450 enzymes by a cocktail method.
    Kang D; Geng T; Lian Y; Li Y; Ding G; Huang W; Ma S; Wang Z; Ma Z; Xiao W
    Biomed Chromatogr; 2017 Jul; 31(7):. PubMed ID: 27891633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.
    Liu S; Wang Z; Chan E; Zhao Y; Kang J; Zhang X; Tian X
    Chem Biol Interact; 2022 Jan; 352():109775. PubMed ID: 34910929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes.
    Yang J; He MM; Niu W; Wrighton SA; Li L; Liu Y; Li C
    Br J Clin Pharmacol; 2012 Feb; 73(2):268-84. PubMed ID: 21815912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput screening of inhibitory effects of Bo-yang-hwan-o-tang on human cytochrome P450 isoforms in vitro using UPLC/MS/MS.
    Lee M; Park J; Lim MS; Seong SJ; Lee J; Seo JJ; Park YK; Lee HW; Yoon YR
    Anal Sci; 2012; 28(12):1197-201. PubMed ID: 23232241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.